My frustration with today's call had very little to do with Nader's communication skills, poor spelling, or the horrific quality of the platform is was broadcast on. What has me perturbed is the fact that as of 3 hours ago I am under the belief (instilled by NP himself just a few days ago) that we have finally arrived and are about to show the world what we can do to save lives right away with the unveiling of the data from the P2./3 SC trial. Was I misled, or did the plan change? Did the plan change because somebody with more experience in such matters advised against cutting the trial short, or did it change because the FDA told them to? Either way, the data from trail that I though would have the most immediate impact has been pushed off 60+ days. By that time, several well capitalized competitors have their data public and their lobbies shaking hands in Washington....now can the m/m P2 trial completely overwhelm the FDA with 80 patient data? Perhaps, but I would say it's unlikely to do so in a manner that avoids a P3 trial. I believe that our product works on COVID, but I also believe that we have surrendered a large lead. We could easily be on the backside of the pandemic before we finish P3 trials.
Introduction to Scilex Holding Company
Pioneering company Scilex Holding Company (Nasdaq: SCLX) is concentrated on the development and marketing of non-opioid pain management solutions. Dedicated to enhancing patient quality of life, Scilex seeks to lead the worldwide pain management solution market. To guarantee responsible pharmaceutical development, the company operates under tight social, environmental, financial, and ethical standards.
Overview of the Master Distributor Agreement
B... Continue Reading
Overview of Above Food's Strategic Acquisition
Leading food company known for its vertically integrated supply chain, Above Food Ingredients Inc. (Nasdaq: ABVE, ABVE.W), has said a major US expansion with the acquisition of The Redwood Group, LLC's Specialty Crop Food Ingredients Division. valued at $34 million, this calculated action consists of 5.6 million recently issued common shares of Above Food combined with $8.1 million in cash. Following usual closing criteria and final adjus... Continue Reading
Hurco and Kawasaki Robotics Join Forces
Leader in CNC machine and control technology Hurco Companies, Inc. (Nasdaq: HURC) has announced a strategic alliance with respected producer of industrial robotics and automation systems Kawasaki Robotics (USA, Inc.). Leveraging over 50 years of Hurco's knowledge in CNC machine tools and controls and Kawasaki's vast industrial robotics expertise, this collaboration combines the strengths of both companies. Taken together, they seek to provide tu... Continue Reading
Introduction to Mangoceuticals’ Innovative Approach
With the release of its recently created DEA-approved telemedicine operating system, Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx") has reached a turning point. The company's goal of providing creative men's health and wellness products—including solutions for erectile dysfunction (ED), hair growth, weight loss, and hormone replacement therapies—is much advanced by this development. MangoRx is dedicated ... Continue Reading
Introduction to ANEW Medical, Inc.
Pioneering biopharmaceutical company ANEW Medical, Inc. (NASDAQ: WENA) is committed to create creative, disease-modifying treatments aiming at the brain and central nervous system (CNS). Among the most difficult neurodegenerative diseases the company targets are Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), and several types of cancer. By means of innovative research and development, ANEW Medical seeks to fulfill major unmet medical ... Continue Reading
Senior Convertible Debt Agreement with Accredited Institutional Investor
Webuy Global Ltd. (Nasdaq: WBUY) announced a new senior convertible debt agreement with an initial principal amount of $2 million. The company could be able to get an extra $4 million, subject to mutual agreement with the accredited institutional investor engaged. Set at $0.213 per share, which is 150% of the company's Class A ordinary shares' volume-weighted average price (VWAP) on the trading day before the not... Continue Reading
The Strategic Importance of Gevo's Net-Zero 1 Facility
Based on a key analysis by Charles River Associates (CRA), Gevo, Inc. (NASDAQ: GEVO) has revealed the major environmental and financial advantages linked with the manufacturing of sustainable aviation fuel (SAF). With a thorough examination of the possible effects, this paper centers on Gevo's intended Net-Zero 1 (NZ1) alcohol-to---jet (ATJ) SAF facility in South Dakota. CRA's research shows that every dollar spent through fed... Continue Reading
Category: StocksTotal Views: 171 By : Caleb PriceUpdated: 08-10-2024
FDA Approves Neffy® Nasal Spray for Severe Allergic Reactions
Leading biopharmaceutical developer of treatments for severe allergic reactions, ARS Pharmaceuticals, Inc. (Nasdaq: SPRY) reached a major turning point with FDA approval of neffy® (epinephrine nasal spray) 2 mg. Now approved for use in adults and children weighing 66 pounds or more experiencing Type I Allergic Reactions, including potentially fatal anaphylaxis, this novel treatment is First needle-free epinephrine delivery ... Continue Reading
Category: StocksTotal Views: 247 By : Riley HayesUpdated: 08-10-2024
Introduction to OneMedNet Corporation
Leading curating and managing of regulatory-grade Real World Data (RWD) is OneMedNet Corporation (Nasdaq: ONMD). By including its own artificial intelligence technology into its data curating procedures, the company has lately made a big advance. Along with simplifying the de-identification of patient data, this invention significantly cut running expenses. OneMedNet has improved its capacity to process enormous volumes of clinical data by using artificia... Continue Reading
Symbotic Expands Capabilities with Strategic Acquisition
Leader in A.I.-enabled robotics technology Symbolic Inc. (Nasdaq: SYM) has made a big advance by acquiring Veo Robotics' assets. This purchase seeks to improve Symbotic's capacity for field-based industrial automation innovation, especially in settings where humans and robots collaborate. By including Veo Robotics' FreeMove® 3D vision system, Symbolic will be able to guarantee worker safety while raising output. Bringing... Continue Reading